article information

Journal of Kermanshah University of Medical Sciences: Vol.13, issue 3; e79599
published online: December 19, 2009
article type: Research Article
received: April 09, 2009
accepted: September 08, 2009

Immunohistochemistry of Inflammatory myofibroblastic tumors

authors:

avatar Mohsen Emami Aleagha 1 , avatar Ahmad Faramarzi 2 , * , avatar Sedigheh Khazaei 2 , avatar Sayed Hamid Madani 2 , avatar Rostam Ghorbani 3

Dept. of pathology, Kermanshah University of Medical Science, Kermanshah, Iran
Dept. of pathology, Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah, Iran
Dept.of Anatomy & Histology, Kermanshah University of Medical Science, Kermanshah, Iran

how to cite: Emami Aleagha M, Faramarzi A, Khazaei S , Madani S H, Ghorbani R. Immunohistochemistry of Inflammatory myofibroblastic tumors. J Kermanshah Univ Med Sci. 2009;13(3):e79599. 

Abstract

Background: Inflammatory myofibroblastic tumor (IMT) or inflammatory pseudotumor is a tumoral lesion which can be seen in all age groups and in all internal organs. It is in  differential diagnosis with some important neoplasms such as Leiomyosarcoma, Rhabdomyosarcoma, and Sarcomatoid carcinoma.  Differentiation between these tumors requires a special diagnostic tool such as Immunohistochemistry (IHC). This study aimed to identify Immunohistochemical characteristics of  inflammatory myofibroblastic tumors.
Methods: 19 cases included in this cross-sectional study. All cases with diagnosis  of :" Inflammatory myofibroblastic tumor" or " Inflammatory pseudotumor" at pathobiology laboratories of Kermanshah university, Tehran Imam Khomaini Hospital and Institute of Cancer were selected and studied by using IHC stains   for CK, EMA, SMA, MSA, Desmin, P53, ALK and Vimentin .
Results: Mean age of cases was 40.4 year . 52.6% were male and 47.4% female. Most frequent affected organs were; Stomach (4 cases), Urinary Bladder (3 cases), Small Intestine (3 cases), Lung and Mediastinum (3cases), Omentum (2 cases), Retroperitoneum (1 case), Cervix(1 case), Urethra(1 case) and gluteus Maximus Muscle (1 case), . Vimentin (94.7%) , MSA (57.9%) and SMA (47.4%) were the most frequent expressed IHC biomarkers in diagnosed tumors  respectively.
Conclusion: CK is a reliable marker for differentiation between these lesions and Sarcomatoid carcinoma. For differentiation from Leiomyosarcoma, Rhabdomyosarcoma and Postoperative Spindle Cell Nodule, using Desmin is a useful biomarker. It is recommended that "IMT"  be used for those lesions that express ALK and/or those that cytogenetic studies reveal a fusion of introducing genes. Other lesions should be classified and reported as "Inflammatory Pseudotumor.

Fulltext

References

  • 1.

    The references of this article is available on PDF.